ArticleJournal of immunology (Baltimore, Md. : 1950)2022

Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors.

Nicholas G Battaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.